1Kwek BH,Aquino SL,Fischman AJ.Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis[J].Chest,2004,125(6):2356-2360.
2Sendhil Kumar Cheran,James E,Herndon II,et al.Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer[J].Lung Cancer,2004,44:317-325.
3F Alatas M,M Metintas,E Harmanci.Demir Diagnostic value of CEA,CA 15-3,CA 19-9,CYFRA 21-1,NSE and TSA assay in pleural effusions [J].Lung Cancer,2001,31:9-16.
4Luis Herna'ndez,Antonia Espasa,Cleofe'Ferna'ndez,et al.CEA and CA 549 in serum and pleural fluid of patients with pleural effusion [J].Lung Cancer,2002,36:83-89.
5Terracciano D,Di Carlo A,Papa P,et al.New approaches in the diagnostic procedure of malignant pleural effusions[J].Oncol Rep,2004,12(1):79-83.
6Ryu JS,Lee HJ,Cho JH,et al.The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion[J].Respirology,2003,8(4):487-491.
7Fuhrman,J.C.Duche,C.Chouaid,et al.Use of Tumor Markers For Differential Diagnosis of Mesothelioma and Secondary Pleural Malignancies[J].Clinical Biochemistry,2000,33( 5):405-410.
8Victoria Villena,Angel Lo'pez-Encuentra,Jose'Echave-Sustaeta,et al.Diagnostic value of CA 549 in pleural fluid.Comparison with CEA,CA 15-3 and CA 72-4[J].Lung Cancer,2003,40:289-294.
9Filiz Kuralay,Zeynep Tokgoz,Abdurrahman Comlekci.Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin[J].Clinical Chimica Acta,2000,300:43-55.
10Luis Valdes,Antonio Pose,Esther San Jose,et al.Tuberculous pleural effusions[J].European Journal of Internal Medicine,2003,14:77-88.
